PLK1 and neoplasm: It has been reported that, equipped with amino-ionizable lipid nanoparticles, Cas9 mRNA and sgRNAs targeting PLK1 could be effectively delivered into aggressive orthotopic glioblastoma, and inhibit the tumor growth (Fig. 3a).